Sevara®

Sorafenib

Product Information

  • Proprietary Name: Sevara®
  • Generic Name: Sorafenib
  • Dosage Form: Film-coated Tablet
  • Strengths: 200 mg
  • Indications: Hepatocellular Carcinoma, Renal Cell Carcinoma, Differentiated Thyroid Carcinoma
Download Leaflet

Oncology

Sevara®

Sorafenib is indicated for the treatment of hepatocellular carcinoma, renal cell carcinoma, and differentiated thyroid carcinoma.

© NanoAlvand. All rights reserved. Powered by ِDGN.